High-dose atorvastatin ameliorates the uterine microenvironment in streptozotocin-induced diabetic rats

References

• Ginter E, Simko V. Type 2 diabetes mellitus, pandemic in 21st century. Adv Exp Med Biol 2012;771:42–50
   PubMed Web of Science ®Google Scholar
• Golden SH. Emerging therapeutic approaches for the management of diabetes mellitus and macrovascular complications. Am J Cardiol 2011;108:59B–67
   Google Scholar
• Edwards MS, Wilson DB, Craven TE, et al. Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study. Am J Kidney Dis 2005;46:214–24
   PubMed Web of Science ®Google Scholar
• Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001;44:129–46
   PubMed Web of Science ®Google Scholar
• Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 2006;212:167–78
   PubMed Web of Science ®Google Scholar
• Li J, Schmidt AM. Characterization and functional analysis of the promoter of rage, the receptor for advanced glycation end products. J Biol Chem 1997;272:16498–506
   PubMed Web of Science ®Google Scholar
• Thornalley PJ, Langborg A, Minhas HS. Formation of glyoxal, methyl glyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 1999;344:109–16
   PubMed Web of Science ®Google Scholar
• Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens 2003;21:3–12
   PubMed Web of Science ®Google Scholar
• Vlassara H, Striker LJ, Teichberg S, et al. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci USA 1994;91:11704–8
   PubMed Web of Science ®Google Scholar
• Martin A, Komada MR, Sane DC. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 2003;23:117–45
   PubMed Web of Science ®Google Scholar
• Platt MJ, Stanisstreet M, Casson IF, et al. St Vincent's declaration 10 years on: outcomes of diabetic pregnancies. Diabet Med 2002;19:216–20
   PubMed Web of Science ®Google Scholar
• Pinent M, Blay M, Blade MC, et al. Grape seed-derived procyanidins have an antihyperglycemic effect in streptozotocin-induced diabetic rats and insulinomimetic activity in insulin-sensitive cell lines. Endocrinology 2004;145:4985–90
   PubMed Web of Science ®Google Scholar
• Yamabe N, Kang KS, Matsuo Y, et al. Identification of antidiabetic effect of iridoid glycosides and low molecular weight polyphenol fractions of corni fructus, a constituent of hachimi-jio-gan, in streptozotocin induced diabetic rats. Biol Pharm Bull 2007;30:1289–96
   PubMed Web of Science ®Google Scholar
• Halcox JP, Deanfield JE. Beyond the laboratory: clinical implications for statin pleiotropy. Circulation 2004;109:1142–8
   Web of Science ®Google Scholar
• Oka H, Ikeda S, Koga S, et al. Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases. Heart Vessel 2008;23:249–56
   PubMed Web of Science ®Google Scholar
• Zhou MS, Jaimes EA, Raij L. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress. Hypertension 2004;44:186–90
   PubMed Web of Science ®Google Scholar
• Shinozaki T, Matsuyama Y, Iimuro S, et al. Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model. Geriatr Gerontol Int 2012;12(Suppl. 1):88–102
   PubMedGoogle Scholar
• Chan KE, Thadhani R, Lazarus JM, Hakim RM. Modeling the 4D study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes. Clin J Am Soc Nephrol 2010;5:856–66
   PubMedGoogle Scholar
• Bellosta S, Ferri N, Arnaboldi L, et al. Pleiotropic effects of statins in atherosclerosis and diabetes. Diabetes Care 2000;23(Suppl. 2):B72–8
   PubMed Web of Science ®Google Scholar
• Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 2001;21:1712–29
   PubMed Web of Science ®Google Scholar
• Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990;343:425–30
   PubMed Web of Science ®Google Scholar
• Van Linthout S, Riad A, Dhayat N, et al. Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy. Diabetologia 2007;50:1977–86
   PubMed Web of Science ®Google Scholar
• Yoshida M, Sawada T, Ishii H, et al. Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism. Arterioscler Thromb Vasc Biol 2001;21:1165–71
   PubMedGoogle Scholar
• Hoffman MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999;97:889–901
   PubMedGoogle Scholar
• Girling JE, Rogers PA. Regulation of endometrial vascular remodeling: role of the vascular endothelial growth factor family and the angiopoietin-TIE signaling system. Reproduction 2009;138:883–93
   PubMedGoogle Scholar
• Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors FASEB J 1999;13:9–22
   PubMed Web of Science ®Google Scholar
• Weis M, Heeschen C, Glassford AJ, Cooke JP. Statins have biphasic effects on angiogenesis. Circulation 2002;105:739–45
   PubMed Web of Science ®Google Scholar
• Urbich C, Dernbach E, Zeiher AM, Dimmeler S. Double-edged role of statins in angiogenesis signaling. Circ Res 2002;90:737–44
   PubMed Web of Science ®Google Scholar
• Oktem M, Esinler I, Eroglu D, et al. High-dose atorvastatin causes regression of endometriotic implants: a rat model. Hum Reprod 2007;22:1474–80
   PubMed Web of Science ®Google Scholar
• Vincent L, Chen W, Hong L, et al. Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect. FEBS Lett 2001;495:159–66
   PubMed Web of Science ®Google Scholar
• Hill DJ. Growth factors and their cellular actions. J Reprod Fertil 1989;85:723–30
   PubMedGoogle Scholar
• Downs SM, Daniel SAJ, Eppig JJ. Induction of maturation in cumulus cell-enclosed mouse oocytes by follicle-stimulating hotmone and epidermal growth factor. Evidence for a positive stimulus of somatic cell origin. J Exp Zool 1988;245:86–96
   PubMedGoogle Scholar
• Prenzel N, Fischer OM, Streit S, et al. The epidermal growth factor receptor family as a central element for cellular signal transduction diversification. Endocr Relat Cancer 2001;8:11–31
   PubMed Web of Science ®Google Scholar
• Fondacci C, Alsat E, Gabriel R, et al. Alterations of human placental epidermal growth factor receptor in intrauterine growth retardation. J Clin Invest 1994;93:1149–55
   PubMedGoogle Scholar